643 results found.
                    
Revenue Review: 3Q18 Performance Highlights and 2018 Projections for Public Companies, Continued
By Mike Evers In the exhibits below, we've added nine companies to round out our revenue review for 3Q18. As noted in last month's 
2018 Year in Review: Revenue Projections and Technology Trends
By Mike Evers In November, we published our downloadable report, 2018 Revenue Projections: Companies Over $200 Million, for the 25 largest orthopaedic companies, shown here in Exhibit 1. Sales for these 25 companies account for approximately 80% of the worldwide orthopaedic market. We p...
3Q18 and 9 Month 2018 Performance Highlights for Public Companies
By Mike Evers Our recap highlights 3Q18 developments and ORTHOWORLD's projection of 2018 full-year revenue for the first publicly traded orthopaedic companies to report. Exhibits 1 and 2 below show year over year company performance for 3Q18 and nine months ending September 30, 2018...
K2M Reports 3Q18 Revenue of $71.4MM, +13.9% vs. 3Q17
K2M reports final quarterly results before acquisition by Stryker, posts 3Q18 revenue of $71.4MM, +13.9%
SeaSpine Reports 3Q18 Revenue of $35.8MM, +12.9% vs. 3Q17
SeaSpine picks up momentum, posts 3Q18 revenue of US $35.8MM, +12.9% vs. 3Q17.
Stryker Completes K2M Acquisition
Stryker closed the previously-announced $1.4BB acquisition of K2M.
OrthoPediatrics Reports 3Q18 Revenue of $15.8MM, +27.8% vs. 3Q17
OrthoPediatrics continues growth with another quarter of record revenues, reports US $15.8MM in 3Q18 sales, +...
Stryker Reports 3Q18 Revenue of $1.6BB, +4.2% vs. 3Q17
Momentum in knee reconstruction drove Stryker’s 3Q18 orthopaedic performance, with revenue of US $1,689.7MM, +4.2% vs. 3Q1...
Stryker Completes Invuity Acquisition
Stryker completed its previously-announced acquisition of Invuity, manufacturer of single-use, lighted visualization instruments.
DePuy Synthes Reports 3Q18 Revenue, -4.2% vs. 3Q17
DePuy Synthes’ 3Q18 orthopaedic performance remains challenged with revenue of US $2,111.3MM, -4.2% vs. 3Q17.
NASS Conversations Reaffirm Spine’s Focus on Additive, Computer-Assisted, Materials
By Carolyn LaWell Speaking with device companies, suppliers and surgeons at the North American Spine Society Annual Meeting (NASS) confirmed our previous thoughts on the health of the spine market and the technologies driving its growth—additive manufacturing, robotics and surface...
Stryker Gains FDA Clearance for SpineJack Fracture Reduction
Stryker received FDA 510(k) clearance for the SpineJack® implantable reduction system to treat osteoporotic verte...
Medtronic to Acquire Mazor Robotics
Medtronic entered into a definitive agreement to acquire Mazor Robotics for US $1.64BB in cash in a transaction that is slated to close in
Spine Company M&A Picks Up in 3Q18
By Rob Meyer and Julie A. Vetalice Eight—yes, eight—spine acquisitions were announced in the four weeks since we published our analysis, “
Joint Reconstruction Expected to Continue with Steady Growth
By Carolyn LaWell Joint reconstruction accounts for 37% of the global orthopaedic industry. We estimate that joint reconstruction product revenue surpassed $18 billion in 2017, an increase of $560.3 million or 3.2% vs. 2016. These numbers were published in
Globus Medical Acquires Nemaris, Surgimap Software
Globus Medical is acquiring Nemaris, developer of Surgimap® software used to preoperatively plan spine surgery...
Stryker Acquires Instrument Manufacturer Invuity
Stryker entered into a definitive agreement to acquire instrument manufacturer Invuity for US $190MM in equity. The transaction i...
Spine Company Sales: ORTHOWORLD Top Ten
Spine...
Stryker Acquiring K2M
Stryker entered into a definitive merger agreement to acquire K2M for ~US $1.4BB in cash. The transaction is slated to close in 4Q18. For 2017, K2M posted revenue of $24...
Revenue Review: 1H18 Growth and 2Q18 Performance Highlights for Public Companies
by Julie A. Vetalice The 21 companies tracked below collectively grew +3.6% in 1H18 vs. 1H17, still on track to reach our estimates of +3.7% in orthopaedic industry growth for 2018 vs. 2017. Exhibits 1 and 2 reflect 1H18 results for public orthopaedic companies. The performan...
Spine Merger & Acquisition Activity Going Strong
By Julie A. Vetalice Updated September 2018 to include additional transactions from 3Q18. Throughout 2017 and thus far in 2018, players of all sizes in the spine segment have taken a variety of steps to fill portfolio gaps, bolster growth and remain competitive. ...
Spine Market Growth Expected to Remain at 2%
By Carolyn LaWell Spine accounts for 18% of the orthopaedic industry’s overall revenue. In 2017, estimated sales of spine products (excluding biologics) exceeded $9 billion worldwide, an increase of 2.2% or $197 million vs. 2016, according to our estimates published in
Viscogliosi Bros. Acquiring OP-1 Portfolio
Ember Therapeutics plans to divest its OP-1 bone morphogenetic protein (BMP-7) portfolio to Viscogliosi Brothers. The transaction...
KFx Medical Sues Stryker on Knotless Fixation Infringement
KFx Medical filed a case against Stryker for continued infringement of a suite of patents related to knotless double row rotato...
Stryker Posts 2Q18 Revenue Growth of 8% YoY
ORTHOWORLD estimates Stryker’s 2Q18 orthopaedic revenue at US $1,747.8MM, +8.0% from 2Q17, and 1H18 revenue at
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2018 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group